CRO further expands global offering with new Indian office

Global data-focused clinical research organisation (CRO), Quanticate, is further expanding its global service offering with a new office in Bangalore, India.

The new 16,500 sq.ft office will act as a base for the company to broaden its capabilities for the management, analysis and reporting of data from clinical trials and post-marketing surveillance.

“By expanding our presence in India, we are able to increase our capacity meaning we can cater for more clients on a larger scale,” explained Praveen Dass, VP of clinical data management and head of Indian operations at Quanticate. “We have an ambitious growth strategy to deliver over the next five years, which aims to employ over 60 new members of staff in the coming months. Our new office provides the perfect platform for this growth and marks an important milestone in our journey.”

Additionally, the new office will be the company’s operational centre of excellence and will enable it to provide customer service for its global client base and support further development of collaborative, long-term partnerships with leading pharmaceutical companies.